Hepatitis C Treatment

Overview and Guides | News & Analysis | General Research | Drugs in Development

Overview and Guides

Treatment of Hepatitis C if You Have HIV/AIDS (May 2012)
From The Well Project
Boceprevir (Victrelis) (April 27, 2012)
To read PDF, click here.
From AIDS InfoNet
Victrelis (Boceprevir) Fact Sheet (April 2012)
To read PDF, click here.
From Treatment Action Group
Incivek (Telaprevir) Fact Sheet (April 2012)
To read PDF, click here.
From Treatment Action Group
Hepatitis C Laboratory Tests (January 23, 2012)
To read PDF, click here.
From AIDS InfoNet
New Mexico: Tele-Treatments -- Video Talks Keep Medical Providers in the Know (January 11, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Telaprevir (Incivek, Incivo) (October 15, 2011)
To read PDF, click here.
From AIDS InfoNet
FDA Supplemental Information About Using Boceprevir and Telaprevir (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
Guide to Clinical Trials for People With Hepatitis C (August 2011)
From Treatment Action Group
Interferon and Ribavirin (June 21, 2011)
To read PDF, click here.
From AIDS InfoNet
Victrelis (Boceprevir) Medication Guide (PDF) (May 2011)
From Merck & Co., Inc.
Patient Information About Victrelis (Boceprevir) (PDF) (May 2011)
From Merck & Co., Inc.
Hepatitis C: Managing Common Symptoms and Treatment Side Effects (March 2011)
From Canadian AIDS Treatment Information Exchange
Clinical Guidelines Update: Hepatitis C Virus in HIV-Infected Patients (May 2010)
To read PDF, click here.
From New York State Department of Health AIDS Institute
Pegylated Interferon (Pegasys, PEG-Intron) (December 29, 2008)
From AIDS Treatment Data Network
Ribavirin (Copegus, Rebetol, Ribasphere) (December 29, 2008)
From AIDS Treatment Data Network
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents: Special Issues (PowerPoint) (November 3, 2008)
61 slides with speaker notes.
From AETC National Resource Center
Clinical Manual: Hepatitis C Treatment (February 23, 2008)
From U.S. Department of Veterans Affairs
Hepatitis C Treatment Today (Fall 2007)
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
Managing Cirrhosis (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
HIV Drugs and HCV Infection (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
HCV Treatment Side Effects and Management Strategies (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
HCV Treatment and People Who Use Drugs (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
Hep C Treatment: Deciding When to Take the Plunge (August 2007)
To read PDF, click here.
In Guide to Hepatitis C for People Living With HIV, from Treatment Action Group
Guide to Hepatitis C for People Living With HIV (August 2007)
Testing, coinfection, treatment and support.
To read PDF, click here.
From Treatment Action Group
An Overview of Peginterferon Alfa-2 (Pegasys, PEG-Intron) (March 16, 2007)
From AIDSinfo
An Overview of Interferon Alfa-2 (Roferon-A, Intron A) (March 13, 2007)
From AIDSinfo
An Overview of Ribavirin (Copegus, Rebetol, Virazole) (February 12, 2007)
From AIDSinfo
Update on Management of the HIV/Hepatitis B- or HIV/Hepatitis C-Coinfected Patient (November 27, 2006)
Summary of current literature.
From TheBodyPRO.com
Hepatitis C: Current Standards of Care and Future Perspectives (May 2006)
To read PDF, click here.
From HCV Advocate
Optimizing Antiretroviral Therapy for HCV-Coinfected People (April-July 2006)
In GMHC Treatment Issues, from Gay Men's Health Crisis
Treatment of Chronic Hepatitis C: Impact on Natural History (January 2006)
To read PDF, click here.
From HCV Advocate
Hepatitis C Virus Disease (December 17, 2004)
[Archived Article]
A chapter from "Treating Opportunistic Infections Among HIV-Infected Adults and Adolescents" guidelines.
To read PDF, click here.
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Hepatitis C Treatment Guidelines: Key Recommendations (October 20, 2004)
To read PDF, click here.
From PositiveWords
Summary of Recommendations in "Hepatitis C Virus (HCV) and HIV/HCV Coinfection: A Critical Review of Research and Treatment" (July 30, 2004)
[Archived Article]
From aidsmap.com
Hepatitis C Virus (HCV) and HIV/HCV Coinfection: A Critical Review of Research and Treatment (July 2004)
[Archived Article]
Treatment Action Group, a prominent U.S. AIDS advocacy organization, has released this detailed report explaining key areas in which hepatitis C infection can be more effectively prevented, monitored and treated throughout the world.
From Treatment Action Group
Hot Topics In Hepatitis C Treatment Research (June 2004)
[Archived Article]
Brian L. Pearlman, M.D., and Joseph E. Paris, Ph.D., M.D., review the most important issues in hepatitis C treatment research over the past two years.
To read PDF, click here.
In HEPP Report, from Brown Medical School
Hepatitis C and Complementary and Alternative Medicine: 2003 Update (May 2004)
[Archived Article]
To read PDF, click here.
From U.S. National Center for Complementary and Alternative Medicine
Minimizing the Impact of Neuropsychiatric Effects During Chronic HCV Disease and Treatment (April 2004)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Hepatitis C Coinfection Review (March/April 2004)
[Archived Article]
An overview of the newest treatments and studies.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
Taking Care of Your Liver (2004)
[Archived Article]
Fifteen tips on how to keep your liver healthy through diet, herbs, vitamins and plain old good sense (from the brochure "Viral Hepatitis and HIV").
To read PDF, click here.
From AIDS Community Research Initiative of America
Management of the Decompensated Cirrhotic Patient with HCV (November 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Access to Care and Treatment for HCV (August 2003)
[Archived Article]
A patient's guide to paying for treatment.
To read PDF, click here.
In WISE Words, from Project Inform
HCV Treatment and Monitoring Guide (August 2003)
[Archived Article]
A basic guide to hepatitis C medications.
To read PDF, click here.
In WISE Words, from Project Inform
How to Monitor HCV and Liver Health (August 2003)
A patient's guide to the treatment and monitoring process.
To read PDF, click here.
In WISE Words, from Project Inform
Liver Transplants: What You Need to Know (August 2003)
[Archived Article]
To read PDF, click here.
In WISE Words, from Project Inform
Hepatitis, Mental Illness, and Substance Abuse: Managing the Triple-Diagnosed HIV Patient (July 2003)
[Archived Article]
Highlights for healthcare professionals from the IAPAC Sessions 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
HCV Services Offered by Drug Treatment Programs in the United States (July 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Managing Those Important Unimportant Side Effects (July 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Management of Hepatitis C Treatment Failure (June 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Patients With Hepatitis C: Who Should Be Treated? (January 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Medical Management of Chronic Hepatitis B and Chronic Hepatitis C (September 2002)
[Archived Article]
An overview of symptoms, treatment options and resources.
To read PDF, click here.
From U.S. Centers for Disease Control and Prevention
Recommendations for Those on the Frontline Against Hepatitis C (August/September 2002)
A guide for correctional health care workers on the management of HCV.
To read PDF, click here.
In HEPP Report, from Brown Medical School
Hepatitis C: Managing the Side Effects (May 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
The Importance of Laboratory Test Results in Hepatitis C Infection (May 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Management of Hepatitis C: 2002 (PDF) (January 1997-April 2002)
[Archived Article]
Bibliographies from the National Library of Medicine, including citations for hepatitis C and HIV/AIDS co-infection.
Managing the HCV Veteran (April 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Hepatitis C: Who Should Be Treated? (February 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Science and Treatment of HIV and Hepatitis C Virus Coinfection (December 2001)
[Archived Article]
An overview of characteristics and management of HIV/HCV coinfection.
In Topics in HIV Medicine
HCV: PEG-Interferons -- When to Use Them (October 23, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from TheBodyPRO.com
HCV: PEG-Interferons -- How to Use Them (October 23, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from TheBodyPRO.com
Treating HEP C: Interferon and Beyond (Fall 1999)
[Archived Article]
An overview of treatment options for HIV/HCV coinfection.
In CRIA Update, from AIDS Community Research Initiative of America
Hepatitis C: A Meeting Ground for the Generalist and the Specialist (January 4, 1999)
[Archived Article]
An overview of HCV diagnosis and treatment.
From U.S. National Institute of Allergy and Infectious Diseases
Recommendations for Prevention and Control of Hepatitis C Virus (HCV) Infection and HCV-Related Chronic Disease (October 16, 1998)
[Archived Article]
To read PDF, click here.
In Morbidity and Mortality Weekly Report, from U.S. Centers for Disease Control and Prevention
Chronic Hepatitis C: Current Disease Management (September 20, 1998)
[Archived Article]
From U.S. National Institutes of Health
Hepatitis C: New Treatment Overview (September 4, 1998)
[Archived Article]
From AIDS Treatment News
Treating Hepatitis C: A Clinician's Perspective (July 1998)
[Archived Article]
An interview with Jerry Powell, M.D.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care

News & Analysis

CDC Urges All Boomers Be Tested for Hepatitis C (May 23, 2012)
From TheBody.com
Incivek Rash Reports: What HIV/Hepatitis C-Coinfected People Need to Know -- A Blog Entry by Barbara McGovern, M.D. (May 17, 2012)
From TheBody.com
Pennsylvania: Thomas Jefferson U. Hospital Opens Hepatitis C Center (May 15, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
CROI's Hep C Treatment News (May/June 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
On TheBodyPRO.com
Victrelis "Not Recommended" With Some HIV Meds (May/June 2012)
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
U.S.: Do Not Mix Merck Hepatitis Pill With HIV Drugs (April 30, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Updated Information on Drug Interactions Between Victrelis (Boceprevir) and Certain Boosted HIV Protease Inhibitor Drugs (April 26, 2012)
From U.S. Food and Drug Administration
Boceprevir a Useful Option for Patients Who Did Not Respond to Earlier Course of Hepatitis C Therapy (April 23, 2012)
From aidsmap.com
Telaprevir and Boceprevir Show High Rate of Serious Side Effects in Hepatitis C Patients With Urgent Need of Treatment (April 20, 2012)
From aidsmap.com
Gilead, Bristol Put Profits Ahead of Best Care for Hep C Patients (April 19, 2012)
One of the most effective new therapies in development for hepatitis C -- daclatasvir plus GS-7977 -- may never see the light of day because the developers seem unable to work together.
From The Street
No Relevant Interactions Between Telaprevir and Two Newest Nonnucleosides Rilpivirine and Etravirine (April 17, 2012)
From National AIDS Treatment Advocacy Project
EASL Starts Tomorrow -- Get Ready for the HCV Treatment Deluge (April 17, 2012)
From Journal Watch
British Columbia Expands Coverage Under PharmaCare Plan for New Drug for Hepatitis C (March 30, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Incivek Triple Therapy Looks Simply Great in HIV/HCV-Coinfected Patients: A Blog Entry by Barbara McGovern, M.D. (March 28, 2012)
From TheBody.com
Victrelis in the Spotlight for HIV/HCV-Coinfected Patients: A Blog Entry by Barbara McGovern, M.D. (March 26, 2012)
From TheBody.com
Merck's Hepatitis C Drug Wins UK Cost Endorsement (March 12, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Vertex, Merck Hepatitis Drugs Work in HIV Patients (March 8, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
Managing Side Effects From New Hepatitis C Drugs (March 2012)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
Interactions Between Certain HIV or Hepatitis C Drugs and Cholesterol-Lowering Statin Drugs Can Increase the Risk of Muscle Injury (March 1, 2012)
From U.S. Food and Drug Administration
Making Sense of the Drug Interaction Warning for HIV/HCV-Coinfected Patients Taking Victrelis: A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
Vitrelis (Boceprevir) in HIV/HCV-Coinfected Patients: A Look at Recent Research -- A Blog Entry by Barbara McGovern, M.D. (February 28, 2012)
From TheBody.com
United Kingdom: Hepatitis C Breakthroughs "Wasted" (February 15, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Merck Says Hepatitis Pill Hampers HIV Drugs (February 13, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
FDA Drug Safety Communication: Important Drug Interactions Between Victrelis (Boceprevir) and Ritonavir-Boosted Human Immunodeficiency Virus (HIV) Protease Inhibitor Drugs (February 8, 2012)
From U.S. Food and Drug Administration
Results of Pharmacokinetic Study in Healthy Volunteers Given Victrelis (Boceprevir) and Ritonavir-Boosted HIV Protease Inhibitors May Indicate Clinically Significant Drug Interactions for Patients Coinfected With Chronic Hepatitis C and HIV (February 6, 2012)
To read PDF, click here.
From Merck & Co., Inc.
Incivek (Telaprevir) in HIV/HCV-Coinfected Patients: A Look at Recent Research -- A Blog Entry by Barbara McGovern, M.D. (February 6, 2012)
From TheBody.com
New Hepatitis C Treatment Available in Australia (February 2, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Looking Forward to a Bright New Year in HIV/HCV Treatment: A Blog Entry by Barbara McGovern, M.D. (January 10, 2012)
From TheBody.com
Top 10 HIV/AIDS-Related Clinical Developments of 2011 (December 1, 2011)
From TheBody.com
Vertex, J&J Hepatitis C Drug Gets European Union Nod (September 22, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection (September 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Hepatitis C Treatment Pipeline (September 2011)
In 2011 Pipeline Report, from Treatment Action Group and HIV i-Base
FDA Approve Telaprevir (Incivek) to Treat Hepatitis C (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
FDA Approve Boceprevir (Victrelis) for HCV (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
European Union Approves Merck's Hepatitis C Drug Victrelis (July 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Q&A on Hepatitis C and African Americans With Jonathan McCone, M.D., Victrelis Researcher (July 6, 2011)
From TheBody.com
New Vertex Ads Focus on Disease, Not the Actual Treatment (June 28, 2011)
In The Boston Globe
Why Incivek and Victrelis Herald a New Era in Hepatitis C Treatment (June 2, 2011)
From TheBody.com
NICE to Appraise Hep C Drugs Victrelis and Telaprevir (May 26, 2011)
In InPharm
FDA Approves Incivek (Telaprevir) for Hepatitis C (May 23, 2011)
From U.S. Food and Drug Administration
Finally, Progress Against a Silent Killer; Brand New Treatment for Hepatitis C Increases Importance of Getting Tested (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Australia: Clinical Experience With the Treatment of Hepatitis C Infection in Patients on Opioid Pharmacotherapy (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
A New Wave of Hepatitis C (May 20, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Merck's Hepatitis C Drug Wins FDA Approval (May 18, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Fair Pricing Coalition Expresses Dismay at the Price of Merck's Newly Approved Hepatitis C Drug (May 17, 2011)
From Fair Pricing Coalition
Approval of Victrelis (Boceprevir), a Direct-Acting Antiviral Drug to Treat Hepatitis C Virus (May 15, 2011)
From U.S. Food and Drug Administration
FDA Approves Victrelis (Bocepravir) for Hepatitis C (May 13, 2011)
From U.S. Food and Drug Administration
HHS Announces New Action Plan to Prevent, Care and Treat Viral Hepatitis (May 12, 2011)
From AIDS.gov
Canada: Regent Park Clinic Offers Hope -- Non-Judgmental Care Keeps Hepatitis C Patients Returning for Treatment (May 11, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Type of Interferon Shows Fewer Side Effects and Better Treatment Rate (April 18, 2011)
From Project Inform
Hepatitis C Advocacy Ramped Up in 2010 (February 2011)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
Vertex Pharma's Hepatitis C Drug Gets Priority Review (January 24, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Hope for Hepatitis C, an Often Hidden Disease (January 21, 2011)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Black Patients Fare Well on Vertex Hepatitis C Drug (November 1, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Access to Hepatitis C Treatment: A Global Movement Gains Momentum (Autumn 2010)
To read PDF, click here.
In TAGline, from Treatment Action Group
Merck Reports Encouraging Results for Hepatitis C Treatment (August 5, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
OraSure Gets OK for First Rapid Hepatitis C Test (June 29, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Canada: Hepatitis C Sufferers Endangering Health to Get Treatment (March 10, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hepatitis C, HIV and the Kidneys (February 2010)
To read PDF, click here.
In Treatment Update, from Canadian AIDS Treatment Information Exchange
Immune Gene May Help Predict Effectiveness of Hepatitis C Therapy (February 2010)
To read PDF, click here.
In Project Inform Perspective, from Project Inform
Antiviral Therapy to Treat Hepatitis C Is Declining in the U.S. (December 9, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hepatitis C: The Changing Picture (Summer 2009)
To read PDF, click here.
In Achieve, from ACRIA and GMHC
Indonesia: Protesters Seek Cheaper Drugs at HIV/AIDS Meeting (August 13, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
State AIDS Drug Assistance Program (ADAP) Hepatitis Coverage (PDF) (Summer 2009)
In TAGline, from Treatment Action Group
Colorado: Hepatitis C Falls Under U.S. Disability Law (July 9, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hepatitis C Link in Colorado Cases Not Found for Weeks (July 7, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Canada: Manitoba Liver Expert Says Too Few Doctors Testing for Hepatitis C (May 21, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Hepatitis C Not a Life Sentence, So Act Early: Doctor (April 22, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
California: Hepatitis C in HIVers May Cause Rapid Liver Disease -- Forum (March 30, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Is a New Generation of HCV Treatment Near? (November 2, 2007)
In The New York Times
Rapidly Progressing Hepatitis C in New York Gay Men (September 2007)
To read PDF, click here.
In TAGline, from Treatment Action Group
Sitges Statement on HIV/HCV Coinfection (September 1, 2007)
From Treatment Action Group
Early Hep C Treatment Is Usually Successful in HIV/Hep C-Coinfected People (July 11, 2007)
From aidsmap.com
Two-Thirds of HIV-Positive Gay Men With Acute Hepatitis C Achieve a Good Response to Hepatitis C Therapy, Small Study Finds (June 11, 2007)
From aidsmap.com
Access to Hepatitis C Treatment Through State AIDS Drug Assistance Programs (ADAPs) (May 31, 2007)
From Treatment Action Group
Drug-Associated Liver Disease During HAART: Impact of HCV Coinfection (June 2006)
To read PDF, click here.
From HCV Advocate
ddI + Ribavirin May Cause Mitochondrial Toxicity (September 1, 2005)
In Journal of Acquired Immune Deficiency Syndromes
In the World of Hepatitis C Treatment, It's All About Teamwork (May/June 2005)
[Archived Article]
A Boston Medical Center team examines how to overcome obstacles to treating HIV/hepatitis C-coinfected people.
From TheBodyPRO.com
Brown University Clinician Leads Way in Providing Competent Care to HIV/Hepatitis C-Coinfected Injection Drug Users (January 2005)
[Archived Article]
In TAGline, from Treatment Action Group
New Hepatitis C Treatment Options Available (September 20, 2004)
Updates on generic ribavirin and the approval of two forms of peg-interferon.
To read PDF, click here.
From PositiveWords
Focus on Hepatitis: Final APRICOT, ACTG A5071 Results (September 2004)
Data indicate that sustained virologic response can be achieved with peginterferon-alfa and ribavirin in many HIV/hepatitis C-coinfected patients.
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
HAART With Protease Inhibitor Less Likely to Show Liver Fibrosis Than HAART With Nevirapine (June 2004)
[Archived Article]
In HEPP Report, from Brown Medical School
National HCV/HIV Coinfection Coalition Meets Capitol Hill (June 2004)
[Archived Article]
In April 2004, advocates visit with congressmembers to push for increased funding for programs helping coinfected people.
In HEPP Report, from Brown Medical School
Undetectable HIV Viral Load Slows Liver Disease Progression in HCV-HIV Co-infection (June 2004)
[Archived Article]
In HEPP Report, from Brown Medical School
Treatment Action Group Responds to U.S. Task Force's Decision Not to Recommend Routine HCV Screening (June 2004)
[Archived Article]
In TAGline, from Treatment Action Group
Expert Panel's Decision to Recommend Against Routine HCV Screening Draws Community Ire (June 2004)
[Archived Article]
In TAGline, from Treatment Action Group
Hepatitis C -- To Treat or Not to Treat? That Is the Question (June 2004)
[Archived Article]
David Thomas, M.D., J.D., discusses the risks and benefits of providing treatment to people with hepatitis C, with a focus on U.S. correctional facilities.
To read PDF, click here.
In HEPP Report, from Brown Medical School
New York: Hepatitis C Treatment Rules for Inmates Continue to Draw Criticism (March 18, 2004)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Pennsylvania Plan to Limit Hepatitis C Treatment in Prisons "Puts Everyone at Risk," Opinion Piece Says (August 15, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Pennsylvania Prison System to Cut Number of Inmates Receiving Treatment for Hepatitis C (July 25, 2003)
[Archived Article]
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation
Senators Introduce Hepatitis C Bill (June 25, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HCV Cirrhosis is a Life Threatening Disease (June 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Colorado: Hispanics Launch Hepatitis C Campaign (May 23, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
University of New Mexico Launches Effort Against Hepatitis C (May 22, 2003)
[Archived Article]
Program trains healthcare workers on management and treatment of hep C.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Oklahoma: State Senator Supports Hepatitis C Education (May 6, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Oregon: Class-Action Lawsuit by Inmates Demands Treatment for Hepatitis C (May 5, 2003)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
HIV Lessons Used in Hepatitis C Treatment (March 11, 2003)
[Archived Article]
New HCV drugs in clinical trials act in similar way to common HIV drugs.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
The Management of Adverse Effects with PEG-Interferon/Ribavirin Combination Therapy is a Significant Challenge (March 2003)
[Archived Article]
To read PDF, click here.
From HCV Advocate
T-20, Pegasys Prices: How High the Sky? (November 2002)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
New Jersey: Inmates Will Get Care for Hepatitis (October 31, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
New Jersey: Former Inmate Sues Over Lack of Hepatitis C Care (October 21, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
FDA Approves Pegasys for Hepatitis C (October 17, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Forty People Unknowingly Got Tissue or Organs From Donor With Hepatitis C; 5 Died (October 4, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Study: Hepatitis Shots Show Promise (September 26, 2002)
[Archived Article]
In a recent study, peginterferon alfa-2a plus ribavirin beats the standard hepatitis C treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
Hepatitis C and Telemedicine Technology: Closing the Gap in Access to Care (September 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Pennsylvania: Prisoner Unlocks Hepatitis C Epidemic (July 31, 2002)
[Archived Article]
An inmate attempts to organize for HCV treatment.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
Promising HCV and HBV Treatments (Summer/Autumn 2002)
[Archived Article]
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
Is Liver Transplant an Option? (Summer 2002)
[Archived Article]
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America
Why Interferon Induction Therapy Has Been a Failure (April 2002)
[Archived Article]
To read PDF, click here.
From HCV Advocate
Important Drug Warning: Intron A (PDF) (December 2001)
[Archived Article]
From U.S. Food and Drug Administration
Plasma Screening Improves (December 2001/January 2002)
[Archived Article]
Food and Drug Administration approves new test to screen plasma for HIV and hepatitis C.
In Positive Living, from AIDS Project Los Angeles
Massachusetts Canceling Hepatitis C Programs (November 2001)
[Archived Article]
In HEPP News, from Brown Medical School
Novel Treatments for HCV (October 21, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from TheBodyPRO.com
Hepatitis C: Progress Beyond Interferon (October 19, 2001)
[Archived Article]
In 66th Annual Scientific Meeting of the American College of Gastroenterology, from TheBodyPRO.com
FDA Approves Peg-Interferon and Ribavirin Treatment Combination (September 21, 2001)
[Archived Article]
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project
Important Drug Warning: Roferon-A (PDF) (September 2001)
[Archived Article]
From U.S. Food and Drug Administration
FDA Approves Stand-Alone Package of Rebetol (Ribavirin) for Combination Therapy With Intron A for the Treatment of Chronic Hepatitis C Infection (July 26, 2001)
[Archived Article]
See also Rebetol (Ribavirin) Product Information (2001) (PDF).
From U.S. Food and Drug Administration
Revised Package Insert: Roferon-A (Interferon Alfa-2a, Recombinant) (PDF) (March 20, 2001)
[Archived Article]
From U.S. Food and Drug Administration
Peg-Interferon-Alfa Approved for Hepatitis C (March 2001)
[Archived Article]
In What's New, from Project Inform
Revised Package Insert: Intron A (Interferon Alfa-2b, Recombinant for Injection) (PDF) (February 2001)
[Archived Article]
From U.S. Food and Drug Administration
Conquering Hepatitis C, Step by Step -- An Editorial (December 7, 2000)
[Archived Article]
In New England Journal of Medicine
New Drugs in Development: Pegylated Interferons for the Treatment of Hepatitis C (Summer 2000)
[Archived Article]
To read PDF, click here.
In CRIA Update, from AIDS Community Research Initiative of America
Ribavirin for Hepatitis C: 80% Price Reduction Available July 9? (July 2, 1999)
[Archived Article]
From AIDS Treatment News
Banding Together to Challenge Schering-Plough's Monopoly on Hepatitis C Treatment (Spring 1999)
[Archived Article]
In Notes From the Underground, from PWA Health Group
Hepatitis Treatment Update (Winter 1998/1999)
[Archived Article]
Rebetron limits patients' options.
In Notes From the Underground, from PWA Health Group
Hepatitis C Drug Pricing Controversy (December 1998)
[Archived Article]
In GMHC Treatment Issues, from Gay Men's Health Crisis
Evolving Strategies to Attack Hepatitis C (December 1998)
[Archived Article]
New treatment combinations are highly toxic but have substantial success rates.
In GMHC Treatment Issues, from Gay Men's Health Crisis
Ribavirin Approved With a Big Fat Price (September 1998)
[Archived Article]
In Notes From the Underground, from PWA Health Group
Can Science Meet the Challenges of the HCV Pandemic? (July 1998)
[Archived Article]
New treatment options for chronic Hepatitis C.
In Journal of the International Association of Physicians in AIDS Care, from International Association of Physicians in AIDS Care
Ribavirin Approved for Hepatitis C Combination Treatment (June 22, 1998)
[Archived Article]
From AIDS Treatment News
Hepatitis C -- Important Treatment Advance (May 15, 1998)
[Archived Article]
An interview with Douglas Dieterich, M.D.
In AIDS Treatment News, from AIDS Treatment News
Hepatitis C and HIV: Ribavirin Plus Interferon Study Recruiting (May 15, 1998)
[Archived Article]
In AIDS Treatment News, from AIDS Treatment News
Alright Thymosin! (April 1996)
[Archived Article]
In Notes From the Underground, from PWA Health Group